Fallahpour S, Navaneelan T, De P, Borgo A (2017) Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data. CMAJ Open 5(3):E734–E739

Article  Google Scholar 

Carafa V, Altucci L, Nebbioso A (2019) Dual tumor suppressor and tumor promoter action of Sirtuins in determining malignant phenotype. Front Pharmacol 10:38

Article  CAS  Google Scholar 

Jin M-S, Hyun CL, Park IA, Kim JY, Chung YR, Im S-A, Lee KH, Moon HG, Ryu HS (2016) SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer. Tumor Biol 37(4):4743–4753

Article  CAS  Google Scholar 

Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23(12):2369–2380

Article  CAS  Google Scholar 

Yi YW, Kang HJ, Kim HJ, Kong Y, Brown ML, Bae I (2013) Targeting mutant p53 by a SIRT1 activator YK-3-237 inhibits the proliferation of triple-negative breast Cancer cells. Oncotarget 4(7):984–994

Article  Google Scholar 

Wang C, Yang W, Dong F, Guo Y, Tan J, Ruan S, Huang T (2017) The prognostic role of Sirt1 expression in solid malignancies: a meta-analysis. Oncotarget 8(39):66343–66351

Article  Google Scholar 

Bosch-Presegué L, Vaquero A (2011) The dual role of sirtuins in cancer. Genes Cancer 2(6):648–662

Article  Google Scholar 

Cao Y-W, Li W-Q, Wan G-X, Li Y-X, Du X-M, Li Y-C et al (2014) Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer. J Exp Clin Cancer Res CR 33:97

Article  Google Scholar 

Chung YR, Kim H, Park SY, Park IA, Jang JJ, Choe J-Y, Jung YY, Im SA, Moon HG, Lee KH, Suh KJ, Kim TY, Noh DY, Han W, Ryu HS (2015) Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype. Hum Pathol 46(7):1027–1035

Article  CAS  Google Scholar 

Jeong SM, Haigis MC (2015) Sirtuins in Cancer: a balancing act between genome stability and metabolism. Mol Cells 38(9):750–758

Article  CAS  Google Scholar 

Ansari A, Rahman MS, Saha SK, Saikot FK, Deep A, Kim K (2017) Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease. Aging Cell 16(1):4–16

Article  CAS  Google Scholar 

He S, He C, Yuan H, Xiong S, Xiao Z, Chen L (2014) The SIRT 3 expression profile is associated with pathological and clinical outcomes in human breast cancer patients. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 34(6):2061–2069

Article  CAS  Google Scholar 

Huang N, Liu Z, Zhu J, Cui Z, Li Y, Yu Y, Sun F, Pan Q, Yang Q (2017) Sirtuin 6 plays an oncogenic role and induces cell autophagy in esophageal cancer cells. Tumor Biol 39(6):1010428317708532

Google Scholar 

Khongkow M, Olmos Y, Gong C, Gomes AR, Monteiro LJ, Yagüe E, Cavaco TB, Khongkow P, Man EPS, Laohasinnarong S, Koo CY, Harada-Shoji N, Tsang JWH, Coombes RC, Schwer B, Khoo US, Lam EWF (2013) SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer. Carcinogenesis 34(7):1476–1486

Article  CAS  Google Scholar 

Deng C-X (2009) SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci 5(2):147–152

Article  CAS  Google Scholar 

Rifaï K, Judes G, Idrissou M, Daures M, Bignon Y-J, Penault-Llorca F, Bernard-Gallon D (2017) Dual SIRT1 expression patterns strongly suggests its bivalent role in human breast cancer. Oncotarget 8(67):110922–110930

Article  Google Scholar 

Lee J-J, Lee HJ, Son B-H, Kim S-B, Ahn J-H, Ahn SD, Cho EY, Gong G (2016) Expression of FOXM1 and related proteins in breast cancer molecular subtypes. Int J Exp Pathol 97(2):170–177

Article  CAS  Google Scholar 

Zhang S, Chen P, Huang Z, Hu X, Chen M, Hu S, Hu Y, Cai T (2015) Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a. Sci Rep 5:9787. https://doi.org/10.1038/srep09787

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hajian-Tilaki K (2013) Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Casp J Intern Med 4(2):627–635

Google Scholar 

Kim H, Kwon YM, Kim JS, Han J, Shim YM, Park J, Kim DH (2006) Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer. Cancer 107(5):1042–1049

Article  CAS  Google Scholar 

Chung SY, Jung YY, Park IA, Kim H, Chung YR, Kim JY, Park SY, Im SA, Lee KH, Moon HG, Noh DY, Han W, Lee C, Kim TY, Ryu HS (2016) Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer. Clin Exp Metastasis 33(2):179–185

Article  CAS  Google Scholar 

Desouki MM, Doubinskaia I, Gius D, Abdulkadir SA (2014) Decreased mitochondrial SIRT3 expression is a potential molecular biomarker associated with poor outcome in breast cancer. Hum Pathol 45(5):1071–1077

Article  CAS  Google Scholar 

Wilking MJ, Ahmad N (2015) The role of SIRT1 in Cancer. Am J Pathol 185(1):26–28

Article  CAS  Google Scholar 

Simic P, Williams EO, Bell EL, Gong JJ, Bonkowski M, Guarente L (2013) SIRT1 suppresses the epithelial-to-Mesenchymal transition in Cancer metastasis and organ fibrosis. Cell Rep 3(4):1175–1186. https://doi.org/10.1016/j.celrep.2013.03.019

Article  CAS  PubMed  Google Scholar 

Yuan J, Minter-Dykhouse K, Lou Z (2009) A c-Myc–SIRT1 feedback loop regulates cell growth and transformation. J Cell Biol 185(2):203–211

Article  CAS  Google Scholar 

Elangovan S, Ramachandran S, Venkatesan N, Ananth S, Gnana-Prakasam JP, Martin PM, Browning DD, Schoenlein PV, Prasad PD, Ganapathy V, Thangaraju M (2011) SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer. Cancer Res 71(21):6654–6664

Article  CAS  Google Scholar 

Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK et al (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107(2):149–159

Article  CAS  Google Scholar 

Wu M, Wei W, Xiao X, Guo J, Xie X, Li L, Kong Y, Lv N, Jia W, Zhang Y, Xie X (2012) Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer. Med Oncol 29(5):3240–3249

Article  CAS  Google Scholar 

Santolla MF, Avino S, Pellegrino M, De Francesco EM, De Marco P, Lappano R et al (2015) SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer. Cell Death Dis 6:e1834

Article  CAS  Google Scholar 

Torrens-Mas M, Pons DG, Sastre-Serra J, Oliver J, Roca P (2017) SIRT3 silencing sensitizes breast Cancer cells to cytotoxic treatments through an increment in ROS production. J Cell Biochem 118(2):397–406

Article  CAS  Google Scholar 

Bae JS, Park S-H, Jamiyandorj U, Kim KM, Noh SJ, Kim JR, Park HJ, Kwon KS, Jung SH, Park HS, Park BH, Lee H, Moon WS, Sylvester KG, Jang KY (2016) CK2α/CSNK2A1 phosphorylates SIRT6 and is involved in the progression of breast carcinoma and predicts shorter survival of diagnosed patients. Am J Pathol 186(12):3297–3315

Article  CAS  Google Scholar 

Igci M, Kalender ME, Borazan E, Bozgeyik I, Bayraktar R, Bozgeyik E, Camci C, Arslan A (2016) High-throughput screening of Sirtuin family of genes in breast cancer. Gene. 586(1):123–128

Article  CAS  Google Scholar 

Wang D, Li C, Zhang X (2014) The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancer. DNA Cell Biol 33(9):581–590

Article  CAS  Google Scholar 

Ioris RM, Galié M, Ramadori G, Anderson JG, Charollais A, Konstantinidou G, Brenachot X, Aras E, Goga A, Ceglia N, Sebastián C, Martinvalet D, Mostoslavsky R, Baldi P, Coppari R (2017) SIRT6 suppresses Cancer stem-like capacity in tumors with PI3K activation independently of its Deacetylase activity. Cell Rep 18(8):1858–1868

Article  CAS  Google Scholar 

Thirumurthi U, Shen J, Xia W, LaBaff AM, Wei Y, Li C-W, et al. (2014) MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer. Sci signal. 7(336):ra71